"Where-there-is-no-psychiatrist Integrated Personal Therapy" Among Community-Dwelling Older Adults
8 de junio de 2021 actualizado por: Shefaly Shorey, National University, Singapore
"Where-there-is-no-psychiatrist Integrated Personal Therapy" Among Community-Dwelling Older Adults: Feasibility Randomized Controlled Trial
The World Health Organization (WHO) reported that approximately 15% of adults aged 60 and above suffer from some form of mental disorder, with one of the most common neuropsychiatric disorders being depression. Similar trends are seen in Singapore where 11.4% of the older adults aged 65 and above had depressive symptoms. Another population survey conducted among elderly in Singapore showed that elderly with subsyndromal depression (SSD) were similar to or worse than elderly with Major Depressive Disorder (MDD). However being a multi-ethnic Asia society the mental conditions such as depression and anxiety are seen as taboo topics to be discussed more so to seek help or treatment for these conditions in Singapore. Additionally scarcity of trained psychiatrists and work load of these trained professionals in the acute care settings make it difficult to reach these needy older adults. Hence, it is imperative to support the needs of this group of community dwelling older adults to ensure that their emotional wellbeing, and their condition do not progress to MDD. As such, this is the first of its kind study that will evaluate the effectiveness of solution focused brief therapy delivered by the lay mindfulness practitioner and the nurses.
If the pilot intervention is found to be feasible and effective, the large scale community trial will be planned to reach to more elderly in Singapore to help them age in a dignified way. In addition, other countries that do not involve lay mindfulness practitioners and nurses to provide integrated personal therapy in the community may benefit from this study as well.
Descripción general del estudio
Estado
Terminado
Intervención / Tratamiento
Tipo de estudio
Intervencionista
Inscripción (Actual)
21
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
-
Singapore, Singapur, 117597
- National University of Singapore
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
60 años a 95 años (Adulto, Adulto Mayor)
Acepta Voluntarios Saludables
No
Géneros elegibles para el estudio
Todos
Descripción
Inclusion Criteria:
- Community-dwelling older adults aged between 60-95 years old
- Able to understand and speak either English and/or Mandarin
- Able to attend at least 80% (five out of seven sessions) of the intervention sessions
- Have subsyndromal depression (obtained a score between one and five on the Geriatric Depression Scale) and/or subsyndromal anxiety (obtained a score between three and 10 on the Geriatric Anxiety Scale)
Exclusion Criteria:
- Older adults aged between 60-95 years old without subsyndromal depression and/or subsyndromal anxiety
- Older adults aged between 60-95 years old who could not understand or speak either English and/or Mandarin.
- Older adults aged between 60-95 years old who were unable to attend at least 80% (five out of seven sessions) of the intervention sessions.
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Sin intervención: Control
Sin intervención
|
|
|
Experimental: Where-there-is-no-psychiatrist Integrated Personal Therapy (WIPT)
Solution-focused brief therapy (SFBT) involving psychoeducation and structured life review therapy, as well as mindfulness-based training
|
The WIPT include weekly face-to-face group sessions including mindfulness-based training and solution focused brief therapy (SFBT) involving psychoeducation and structured life review therapy catered to the personal needs of the participants.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Symptoms of depression
Periodo de tiempo: Prior to start of intervention
|
Measured using Geriatric Depression Scale.
15-item scale where participants select either "Yes" or "No" in response to 15 statements.
The maximum score that could be obtained was 15 points; a high score on the scale indicates severe depressive symptoms.
|
Prior to start of intervention
|
|
Symptoms of depression
Periodo de tiempo: 3 months post-recruitment
|
Measured using Geriatric Depression Scale.
15-item scale where participants select either "Yes" or "No" in response to 15 statements.
The maximum score that could be obtained was 15 points; a high score on the scale indicates severe depressive symptoms.
|
3 months post-recruitment
|
|
Symptoms of depression
Periodo de tiempo: 6 months post-recruitment
|
Measured using Geriatric Depression Scale.
15-item scale where participants select either "Yes" or "No" in response to 15 statements.
The maximum score that could be obtained was 15 points; a high score on the scale indicates severe depressive symptoms.
|
6 months post-recruitment
|
|
Symptoms of anxiety
Periodo de tiempo: Prior to start of intervention
|
Measured using Geriatric Anxiety Inventory.
20-item scale where participants select either "Agree" or "Disagree" to assess the anxiety symptoms in older adults.
The maximum score that could be obtained was 20 points; a high score indicates more anxiety symptoms.
|
Prior to start of intervention
|
|
Symptoms of anxiety
Periodo de tiempo: 3 months post-recruitment
|
Measured using Geriatric Anxiety Inventory.
20-item scale where participants select either "Agree" or "Disagree" to assess the anxiety symptoms in older adults.
The maximum score that could be obtained was 20 points; a high score indicates more anxiety symptoms.
|
3 months post-recruitment
|
|
Symptoms of anxiety
Periodo de tiempo: 6 months post-recruitment
|
Measured using Geriatric Anxiety Inventory.
20-item scale where participants select either "Agree" or "Disagree" to assess the anxiety symptoms in older adults.
The maximum score that could be obtained was 20 points; a high score indicates more anxiety symptoms.
|
6 months post-recruitment
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Life satisfaction
Periodo de tiempo: Prior to start of intervention
|
Measured using Satisfaction with Life Scale.
5-item scale that included a 7-point Likert scale (1 = "Strongly Disagree"; 7 = "Strongly Agree").
The maximum score that could be obtained was 35 points; a high score indicates high level of satisfaction with life.
|
Prior to start of intervention
|
|
Life satisfaction
Periodo de tiempo: 3 months post-recruitment
|
Measured using Satisfaction with Life Scale.
5-item scale that included a 7-point Likert scale (1 = "Strongly Disagree"; 7 = "Strongly Agree").
The maximum score that could be obtained was 35 points; a high score indicates high level of satisfaction with life.
|
3 months post-recruitment
|
|
Life satisfaction
Periodo de tiempo: 6 months post-recruitment
|
Measured using Satisfaction with Life Scale.
5-item scale that included a 7-point Likert scale (1 = "Strongly Disagree"; 7 = "Strongly Agree").
The maximum score that could be obtained was 35 points; a high score indicates high level of satisfaction with life.
|
6 months post-recruitment
|
|
Social connectedness in terms of friendship
Periodo de tiempo: Prior to start of intervention
|
Measured using Friendship Scale.
6-item where participants had to select an answer out of the five options (1 = "Not at All"; 5 = "Almost Always").
The maximum score that could be obtained was 30 points; a high score indicates high level of social connectedness.
|
Prior to start of intervention
|
|
Social connectedness in terms of friendship
Periodo de tiempo: 3 months post-recruitment
|
Measured using Friendship Scale.
6-item where participants had to select an answer out of the five options (1 = "Not at All"; 5 = "Almost Always").
The maximum score that could be obtained was 30 points; a high score indicates high level of social connectedness.
|
3 months post-recruitment
|
|
Social connectedness in terms of friendship
Periodo de tiempo: 6 months post-recruitment
|
Measured using Friendship Scale.
6-item where participants had to select an answer out of the five options (1 = "Not at All"; 5 = "Almost Always").
The maximum score that could be obtained was 30 points; a high score indicates high level of social connectedness.
|
6 months post-recruitment
|
|
Quality of life
Periodo de tiempo: Prior to start of intervention
|
Measured using World Health Organization Quality of Life-Older Adults module.
13-item scale where participants had to select an answer based on a 5-point rating scale (1 = "Not at All"; 5 = "Very Satisfied").
The maximum score was 65 points, and a high score indicates high quality of life.
|
Prior to start of intervention
|
|
Quality of life
Periodo de tiempo: 3 months post-recruitment
|
Measured using World Health Organization Quality of Life-Older Adults module.
13-item scale where participants had to select an answer based on a 5-point rating scale (1 = "Not at All"; 5 = "Very Satisfied").
The maximum score was 65 points, and a high score indicates high quality of life.
|
3 months post-recruitment
|
|
Quality of life
Periodo de tiempo: 6 months post-recruitment
|
Measured using World Health Organization Quality of Life-Older Adults module.
13-item scale where participants had to select an answer based on a 5-point rating scale (1 = "Not at All"; 5 = "Very Satisfied").
The maximum score was 65 points, and a high score indicates high quality of life.
|
6 months post-recruitment
|
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Cortisol in ng/ml
Periodo de tiempo: Prior to start of intervention
|
Stress- and anxiety- related inflammatory outcomes.
Collected in lithium heparin tubes
|
Prior to start of intervention
|
|
Cortisol in ng/ml
Periodo de tiempo: 6 months post-recruitment
|
Stress- and anxiety- related inflammatory outcomes.
Collected in lithium heparin tubes
|
6 months post-recruitment
|
|
Annexin-A1 in ng/ml
Periodo de tiempo: Prior to start of intervention
|
Stress- and anxiety- related inflammatory outcomes.
Collected in lithium heparin tubes
|
Prior to start of intervention
|
|
Annexin-A1 in ng/ml
Periodo de tiempo: 6 months post-recruitment
|
Stress- and anxiety- related inflammatory outcomes.
Collected in lithium heparin tubes
|
6 months post-recruitment
|
|
Interleukin-1-beta in pg/ml
Periodo de tiempo: Prior to start of intervention
|
Stress- and anxiety- related inflammatory outcomes.
Collected in lithium heparin tubes
|
Prior to start of intervention
|
|
Interleukin-1-beta in pg/ml
Periodo de tiempo: 6 months post-recruitment
|
Stress- and anxiety- related inflammatory outcomes.
Collected in lithium heparin tubes
|
6 months post-recruitment
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
1 de septiembre de 2019
Finalización primaria (Actual)
31 de enero de 2020
Finalización del estudio (Actual)
31 de marzo de 2020
Fechas de registro del estudio
Enviado por primera vez
1 de junio de 2021
Primero enviado que cumplió con los criterios de control de calidad
8 de junio de 2021
Publicado por primera vez (Actual)
15 de junio de 2021
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
15 de junio de 2021
Última actualización enviada que cumplió con los criterios de control de calidad
8 de junio de 2021
Última verificación
1 de junio de 2021
Más información
Términos relacionados con este estudio
Otros números de identificación del estudio
- A17-2003-B
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
No
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .